“Incidence of Adverse and Safety Events in Individuals With Parkinson’s Disease Treated With Catechol-O-Methyltransferase Inhibitor Opicapone As an Add-on to Levodopa Treatment: A Systematic Review and Meta-Analysis”. Prospects in Pharmaceutical Sciences, vol. 23, no. 4, Aug. 2025, pp. 175-8, https://doi.org/10.56782/pps.563.